格列卡韦/皮布伦他韦在慢性丙型肝炎或代偿性肝硬化患者日常临床应用中的安全性和有效性：药物使用结果调查

{"title":"格列卡韦/皮布伦他韦在慢性丙型肝炎或代偿性肝硬化患者日常临床应用中的安全性和有效性：药物使用结果调查","authors":"S. Mochida, Toshihisa Matsuzaki, K. Kawana, Kaoru Ohchi, R. Sakuma, M. Kurosaki","doi":"10.2957/kanzo.63.120","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":35810,"journal":{"name":"Acta Hepatologica Japonica","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Safety and effectiveness of glecaprevir/pibrentasvir in patients with chronic hepatitis C or compensated cirrhosis in daily clinical practice: a drug-use results survey\",\"authors\":\"S. Mochida, Toshihisa Matsuzaki, K. Kawana, Kaoru Ohchi, R. Sakuma, M. Kurosaki\",\"doi\":\"10.2957/kanzo.63.120\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":35810,\"journal\":{\"name\":\"Acta Hepatologica Japonica\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Hepatologica Japonica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2957/kanzo.63.120\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Hepatologica Japonica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2957/kanzo.63.120","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}